1. Home
  2. SACH vs SER Comparison

SACH vs SER Comparison

Compare SACH & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$1.05

Market Cap

48.6M

Sector

Real Estate

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$3.91

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SACH
SER
Founded
2010
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.6M
42.0M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
SACH
SER
Price
$1.05
$3.91
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$2.00
$13.00
AVG Volume (30 Days)
150.4K
20.3K
Earning Date
11-05-2025
11-13-2025
Dividend Yield
19.42%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,906,000.00
$116,000.00
Revenue This Year
N/A
$134.46
Revenue Next Year
$6.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$3.55
52 Week High
$1.65
$7.92

Technical Indicators

Market Signals
Indicator
SACH
SER
Relative Strength Index (RSI) 46.23 48.89
Support Level $0.96 $3.68
Resistance Level $1.08 $4.12
Average True Range (ATR) 0.05 0.30
MACD 0.00 0.05
Stochastic Oscillator 53.85 67.71

Price Performance

Historical Comparison
SACH
SER

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: